Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib

類似資料

• Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial
  著者:: Sartore-Bianchi, Andrea, 等
  出版事項: (2020)
• HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
  著者:: Sartore‐Bianchi, Andrea, 等
  出版事項: (2019)
• Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case
  著者:: Martinelli, Erika, 等
  出版事項: (2018)
• Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer
  著者:: Montemurro, Filippo, 等
  出版事項: (2013)
• Role of trastuzumab in the management of HER2-positive metastatic breast cancer
  著者:: Milani, Andrea, 等
  出版事項: (2010)